The plasma coagulation cascade: potential targets for novel anticoagulants in major lower limb surgery.
Strategies for prevention of venous thromboembolism in orthopaedic patients undergoing major lower limb surgery include pharmacological prophylaxis. Over the last three decades, the search for new safe and effective approaches for the prevention of venous thromboembolism in these patients has continued. Increased understanding of the haemostatic process has led to a clearer appreciation of the mechanisms of action of antithrombotic drugs already in use as well as the identification of new targets for novel drug development. As a result, the development of new anticoagulants has advanced rapidly over recent years. The molecular targets of several novel anticoagulants, and their effectiveness in early Phase II and Phase III trials are reviewed.
Department of Anatomy, University of Athens, School of Medicine, Athens, Greece. ejohnson@cc.uoi.gr
Elizabeth O
EO
Johnson
Maria
M
Konstandi
George C
GC
Babis
Mara
M
Piagkou
Panayotis N
PN
Soucacos
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D035002:Lower Extremity / Q000601:surgery*; D019637:Orthopedic Procedures / Q000009:adverse effects* / Q000379:methods; D054556:Venous Thromboembolism / Q000097:blood* / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents